BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23936024)

  • 41. KIAA1199 interacts with glycogen phosphorylase kinase β-subunit (PHKB) to promote glycogen breakdown and cancer cell survival.
    Terashima M; Fujita Y; Togashi Y; Sakai K; De Velasco MA; Tomida S; Nishio K
    Oncotarget; 2014 Aug; 5(16):7040-50. PubMed ID: 25051373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
    Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
    Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Downregulation of KIAA1199 by miR-486-5p suppresses tumorigenesis in lung cancer.
    Wang A; Zhu J; Li J; Du W; Zhang Y; Cai T; Liu T; Fu Y; Zeng Y; Liu Z; Huang JA
    Cancer Med; 2020 Aug; 9(15):5570-5586. PubMed ID: 32519472
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Upregulation of the KIAA1199 gene is associated with cellular mortality.
    Michishita E; Garcés G; Barrett JC; Horikawa I
    Cancer Lett; 2006 Jul; 239(1):71-7. PubMed ID: 16157444
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protein phosphatase 2A is essential to maintain active Wnt signaling and its Aβ tumor suppressor subunit is not expressed in colon cancer cells.
    Carmen Figueroa-Aldariz M; Castañeda-Patlán MC; Santoyo-Ramos P; Zentella A; Robles-Flores M
    Mol Carcinog; 2015 Nov; 54(11):1430-41. PubMed ID: 25252130
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LINC00261 suppresses human colon cancer progression via sponging miR-324-3p and inactivating the Wnt/β-catenin pathway.
    Yan D; Liu W; Liu Y; Luo M
    J Cell Physiol; 2019 Dec; 234(12):22648-22656. PubMed ID: 31183860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/β-catenin signaling pathway and predicts good prognosis.
    Wu Y; Fang G; Wang X; Wang H; Chen W; Li L; Ye T; Gong L; Ke C; Cai Y
    Cancer Biomark; 2019; 24(1):61-70. PubMed ID: 30347601
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinicopathologic significance of KIAA1199 overexpression in human gastric cancer.
    Matsuzaki S; Tanaka F; Mimori K; Tahara K; Inoue H; Mori M
    Ann Surg Oncol; 2009 Jul; 16(7):2042-51. PubMed ID: 19434458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ectodysplasin A receptor (EDAR) promotes colorectal cancer cell proliferation via regulation of the Wnt/β-catenin signaling pathway.
    Wang B; Liang Y; Chai X; Chen S; Ye Z; Li R; Li X; Kong G; Li Y; Zhang X; Che Z; You Y; Ye S; Li L; Lin B; Huang J; Huang M; Zhang X; Qiu X; Zeng J
    Exp Cell Res; 2020 Oct; 395(1):112170. PubMed ID: 32682783
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ZNF281 Regulates Cell Proliferation, Migration and Invasion in Colorectal Cancer through Wnt/β-Catenin Signaling.
    Qin CJ; Bu PL; Zhang Q; Chen JT; Li QY; Liu JT; Dong HC; Ren XQ
    Cell Physiol Biochem; 2019; 52(6):1503-1516. PubMed ID: 31112017
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
    Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
    Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancers.
    Piazzi G; Selgrad M; Garcia M; Ceccarelli C; Fini L; Bianchi P; Laghi L; D'Angelo L; Paterini P; Malfertheiner P; Chieco P; Boland CR; Bazzoli F; Ricciardiello L
    Br J Cancer; 2013 Apr; 108(8):1750-6. PubMed ID: 23579212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcriptional and epigenetic regulation of KIAA1199 gene expression in human breast cancer.
    Kuscu C; Evensen N; Kim D; Hu YJ; Zucker S; Cao J
    PLoS One; 2012; 7(9):e44661. PubMed ID: 22970280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor Suppressive Role of ARHGAP17 in Colon Cancer Through Wnt/β-Catenin Signaling.
    Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
    Cell Physiol Biochem; 2018; 46(5):2138-2148. PubMed ID: 29730655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dickkopf-Related Protein 2 is Epigenetically Inactivated and Suppresses Colorectal Cancer Growth and Tumor Metastasis by Antagonizing Wnt/β-Catenin Signaling.
    Wang C; Yue Y; Shao B; Qiu Z; Mu J; Tang J; Han X; Xiang T; Ren G
    Cell Physiol Biochem; 2017; 41(5):1709-1724. PubMed ID: 28365691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Transition Zone Showing Highly Discontinuous or Alternating Levels of Stem Cell and Proliferation Markers Characterizes the Development of PTEN-Haploinsufficient Colorectal Cancer.
    Arvai KJ; Hsu YH; Lee LA; Jones D
    PLoS One; 2015; 10(6):e0131108. PubMed ID: 26098881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Up-regulated NRIP2 in colorectal cancer initiating cells modulates the Wnt pathway by targeting RORβ.
    Wen Z; Pan T; Yang S; Liu J; Tao H; Zhao Y; Xu D; Shao W; Wu J; Liu X; Wang Y; Mao J; Zhu Y
    Mol Cancer; 2017 Jan; 16(1):20. PubMed ID: 28137278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ADNP Is a Therapeutically Inducible Repressor of WNT Signaling in Colorectal Cancer.
    Blaj C; Bringmann A; Schmidt EM; Urbischek M; Lamprecht S; Fröhlich T; Arnold GJ; Krebs S; Blum H; Hermeking H; Jung A; Kirchner T; Horst D
    Clin Cancer Res; 2017 Jun; 23(11):2769-2780. PubMed ID: 27903678
    [No Abstract]   [Full Text] [Related]  

  • 59. β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.
    Satow R; Shitashige M; Jigami T; Fukami K; Honda K; Kitabayashi I; Yamada T
    Gastroenterology; 2012 Mar; 142(3):572-81. PubMed ID: 22155184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.